Association Between Clinical Outcomes and Hospital Guidelines for Cerebrospinal Fluid Testing in Febrile Infants Aged 29-56 Days
Overview
Affiliations
Objective: To describe the association between clinical outcomes and clinical practice guidelines (CPGs) recommending universal cerebrospinal fluid (CSF) testing in the emergency department for febrile infants aged 29-56 days.
Study Design: Using 2007-2013 administrative data from 32 US children's hospitals, we performed a difference-in-differences analysis comparing 7 hospitals with CPGs recommending universal CSF testing for older febrile infants aged 29-56 days (CPG group) with 25 hospitals without such CPGs (control group). We compared differences in clinical outcomes between older febrile infants with the corresponding differences among younger febrile infants aged 7-28 days. The primary outcome was the occurrence of an adverse event, defined as a delayed diagnosis of bacterial meningitis, mechanical ventilation, placement of a central venous catheter, extracorporeal membrane oxygenation, or in-hospital mortality. Analyses were adjusted for race/ethnicity, sex, median annual household income by zip code, primary insurance source, discharge season, and discharge year.
Results: The proportion of older febrile infants undergoing CSF testing was higher (P < .001) in the CPG group (64.8%) than the control group (47.8%). CPGs recommending universal CSF testing for older febrile infants were not associated with significant differences in adverse events (difference-in-differences: +0.31 percentage points, 95% CI -0.18 to 0.85; P = .22).
Conclusions: Hospital CPGs recommending universal CSF testing for febrile infants aged 29-56 days were not associated with significant differences in clinical outcomes.
Boston Febrile Infant Algorithm 2.0: Improving Care of the Febrile Infant 1-2 Months of Age.
Dorney K, Neuman M, Harper M, Bachur R Pediatr Qual Saf. 2022; 7(6):e616.
PMID: 36337736 PMC: 9622664. DOI: 10.1097/pq9.0000000000000616.
Gutman C, Lion K, Aronson P, Fisher C, Bylund C, McFarlane A BMJ Open. 2022; 12(9):e063611.
PMID: 36127098 PMC: 9490627. DOI: 10.1136/bmjopen-2022-063611.
Use of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days.
Widmer K, Schmidt S, Bakel L, Cookson M, Leonard J, Tyler A Hosp Pediatr. 2021; 11(3):223-230.
PMID: 33597148 PMC: 8287898. DOI: 10.1542/hpeds.2020-000380.
Rabiner J, Capua M, Golfeiz D, Shoag J, Avner J Glob Pediatr Health. 2019; 6:2333794X19845076.
PMID: 31069251 PMC: 6492348. DOI: 10.1177/2333794X19845076.
Analgesia for lumbar puncture in infants and children.
Goldman R Can Fam Physician. 2019; 65(3):192-194.
PMID: 30867175 PMC: 6515948.